Moderna Inc. said its experimental vaccine for Covid-19 could be available to a select few as soon as this fall, ahead of expectations for a commercial release in a year.
A potential vaccine is not expected to be commercially available for at least a year. Moderna is also scaling up manufacturing capacity so it can produce millions of doses each month, the company said.
Moderna’s stock rose as much as 2.7% on Monday after a
(Updates to add share move, chart)
To contact the reporter on this story:
To contact the editors responsible for this story:
© 2020 Bloomberg L.P. All rights reserved. Used with permission.